First Time Loading...
Search stocks here...
Dashboard Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing About Contact Us
Sign Up Log in

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 1.62 USD -8.47% Market Closed
Updated: May 31, 2023
Section:
 

Wall Street
Price Targets

ATRA Price Targets Summary
Atara Biotherapeutics Inc

There are no price targets for ATRA.
ATRA Lowest Forecast
Wall Street Target
Not Available
ATRA Average Forecast
Wall Street Target
Not Available
ATRA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Atara Biotherapeutics Inc Competitors:
Price Targets
OCC
Orthocell Ltd
58% Upside
A
ACXP
Acurx Pharmaceuticals Inc
374% Upside
HZNP
Horizon Therapeutics PLC
21% Upside
DYAI
Dyadic International Inc
243% Upside
OCC
Orthocell Ltd
58% Upside
A
ACXP
Acurx Pharmaceuticals Inc
374% Upside
HZNP
Horizon Therapeutics PLC
21% Upside
DYAI
Dyadic International Inc
243% Upside
B
2137
Brii Biosciences Ltd
222% Upside
P
PROB
Probi AB
75% Upside
TNG
Transgene SA
138% Upside
GMAB
Genmab A/S
163% Upside

Revenue
Forecast

Revenue Estimate
Atara Biotherapeutics Inc

N/A
Past CAGR
28%
Future CAGR

Operating Income
Forecast

Operating Income Estimate
Atara Biotherapeutics Inc

N/A
Past CAGR
N/A
Future CAGR

Net Income
Forecast

Net Income Estimate
Atara Biotherapeutics Inc

N/A
Past CAGR
N/A
Future CAGR

See Also

Summary
ATRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATRA stock valuation using valuation multiples.
Wall Street Estimates
ATRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Other Stocks
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRA's stock price target?

ATRA doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 54,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy Affiliate Program

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2023 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.